COMMUNITY

ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ
Community

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÇÁ·Î¸ð¼Ç

ÇÁ·Î¸ð¼Ç

ÇÑÁ¤±â°£ ¾Æ¹Ù¹ÙÀÌ¿À Á¦°øÇϴ Ưº°ÇÑ °¡°Ý
Á¦¸ñ [BACHEM] Peptide Trends June 2019 – Oxytocin Peptides
ÀÛ¼ºÀÚ abbabio
ÀÛ¼ºÀÏÀÚ 2019-06-20
Á¶È¸¼ö 479

 MANAGE YOUR SUBSCRIPTION
BACHEM  PIONEERING  PARTNER  FOR PEPTIDES
 PEPTIDE TRENDS
June 2019 EDITION
MEET US AT THE AMERICAN PEPTIDE SYMPOSIUM
The American Peptide Symposium is a biennial event organized by the American Peptide Society, a nonprofit scientific and educational organization dedicated to advancing and promoting knowledge of the chemistry and biology of peptides. The 26th American Peptide Symposium will be held on June 22 to 27, 2019 in Monterey, CA.
 
We invite you to visit us at our Booth #39: we are excited to meet with you, learn your needs for peptides and discuss how Bachem can assist to advance your research.
 
We look forward to meeting you at APS 2019!
 
Read More



OXYTOCIN PEPTIDES
Oxytocin is a neurohypophysial hormone, which was first identified for its important function in stimulating uterine contraction and milk let down after birth. During the last decades it became evident that oxytocin not only has an impact on social and bonding behaviors related to reproduction and care for offspring, but also has an effect on a variety of other behaviors such as anxiety and reward-related feeding.
 
Read More

OXYTOCIN PEPTIDES IN CLINICAL DEVELOPMENT
Oxytocin first entered the pharmaceutical market in 1980 as Pitocin¢ç and Syntocinon¢ç. In the field of women¢¥s health, these drugs are still used today for labor induction and for the treatment of post-partum hemorrhage. Oxytocin is also of interest for treating a wide range of diseases and disorders such as autism spectrum disorders (ASD), addictive disorders, diabetes and obesity. Currently, there are oxytocin and oxytocin derived drug candidates in clinical development for various indications.
 
Read More

MEET BACHEM: DIETMAR LEIPERT, GROUP LEADER R&D
This month the spotlight is on Dietmar Leipert, group leader R&D at Bachem AG.
 
Learn about Dietmar¢¥s role at Bachem and what he likes to do in his free time.
 
Read More



PEPTIDE HIGHLIGHTS
This month's highlights include news about synthetic peptides that target toxic amyloid ¥â-peptide oligomers in Alzheimer¢¥s disease, the development of an arsenic-peptide complex to target cancer, intranasal oxytocin administration as a potential treatment for alcoholism, and a novel therapeutic target for atherosclerosis.
 
Read More



LITERATURE CITATIONS
Bachem peptides and biochemicals are frequently cited in research publications. View a selection of recent articles that cite Bachem`s peptides.
 
Read More



Marketing
Dr. Martina Diekmann
Vice President Global Marketing

cell +41 79 945 9107
Marketing
Stefan Andlauer, EMBA
Director Science & Relationship Marketing
phone +41 58 595 2107
CHAT WITH US!


MEET BACHEM AT UPCOMING EXHIBITS AND EVENTS
 
American Peptide Symposium
Monterey, CA, USA
June 22-27, 2019

MRC LMB-GGNB Graduate Student Symposium
Cambridge, UK
July 10-12, 2019

Alzheimer¢¥s Association International Conference
Los Angeles, CA, USA
July 12-18, 2019

IMAP 2019
Utrecht, NL
August 28-30, 2019

Make an appointment and meet us in person. Contact  
|sasas

Bachem logo

          
Contact Us

Americas:
Bachem Americas, Inc.
Toll Free (USA and Canada): +1 888 422 2436 or Tel: +1 310 539 4171



Asia Pacific:
Bachem Japan K.K.
Tel:
+81 3 6661 0774

Europe, Africa, Middle East and India:
Bachem AG
Tel: +41 58 595 2020


Visit our website at
www.bachem.com

All information is compiled to the best of our knowledge. We cannot be made liable for any possible errors or misprints.
Some products may be restricted in certain countries.

© 2019 Global Marketing Bachem Group

To change your subscription, please use the Manage Your Subscription link at the top or bottom of this email.

÷ºÎÆÄÀÏ